Mina Lobbous on Muck Rack

Mina Lobbous

As seen in: Nature, Wiley Online Library, American Journal of Managed Care, OncLive, NeurologyLive, Targeted Oncology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Mina

Contact Mina, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Tucatinib–trastuzumab–capecitabine for treatment of leptomeningeal metastasis in women with HER2 + breast cancer: TBCRC049 phase 2 study results

|
By Rashmi Murthy, Barbara J O’Brien, Donald Berry, Maria Monroe, Jason Johnson, Jason WHite, Jason White, Mina Lobbous, Kristen E Riley, Michelle E. Melisko, Aki Morikawa, Sherise D Ferguson, John de Groot, Ian Krop, Vicente Valero, Mothaffar F. Rimawi, Antonio C. Wolff, Debu Tripathy, Nancy Lin, Erica M Stringer-Reasor, Akshara Singareeka-Raghavendra, Jill Schwartz-Gomez, Ariel Topletz-Erickson
| Nature Verified
Abstract Treatments for leptomeningeal metastasis (LM) are limited and prognosis is poor. In this phase 2, nonrandomized, single-arm, multicenter study, we evaluated a tucatinib–trastuzumab–capecitabine regimen in patients with newly diagnosed LM and human epidermal growth factor receptor 2-positive (HER2+) breast cancer.
Open in Who Shared Issue with article?
See all 1 licensed articles (22 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified